{"content":[{"key":"header","data":{"level":2,"content":"三、颈部"},"common":{"quote":false}},{"key":"header","data":{"content":"（一）喉部、甲状腺、甲状旁腺MRI技术要点及要求","level":3},"common":{"quote":false}},{"key":"list","data":{"style":"ordered","items":[{"content":"﻿﻿线圈：颈线圈、头颈联合线圈、脊柱相控阵线圈。","style":"unordered","closed":false,"items":[]},{"content":"﻿﻿体位：仰卧位，头先进。定位中心及线圈中心对准喉结。","style":"unordered","closed":false,"items":[]},{"content":"﻿﻿﻿方位及序列：平扫序列：以轴面为主，扫描T<sub>2</sub>WI、 fs-T<sub>2</sub>WI［短时间反转恢复（short time inversion recovery,STIR）序列或水脂分离］和T<sub>1</sub>WI序列，辅以矢状面T<sub>2</sub>WI和T<sub>1</sub>WI及冠状面fs-T<sub>2</sub>WI（STIR或水脂分离）。扫描基线：轴面：垂直于喉腔长轴，范围上含会厌上缘，下至第六颈椎体下缘水平；矢状面：平行于喉咽腔正中矢状线，范围包含喉部两侧软组织外缘；冠状面：平行于喉咽腔长轴，范围覆盖喉结至乳突后。增强扫描序列：轴面、矢状面及冠状面fs-T<sub>1</sub>WI均需扫描。","style":"unordered","closed":false,"items":[]},{"content":"﻿﻿技术参数：基本原则为适当提高空间分辦率。层厚≤3.0mm，层间隔≤层厚x10%，FOV（200~230）mm × （200~230）mm，矩阵≥256×224。按照常规剂量和流率静脉注射钆对比剂。","style":"unordered","closed":false,"items":[]},{"content":"图像要求：（1）显示喉部、甲状腺、甲状旁腺细微解剖结构，两侧对称显示；（2）颈部淋巴结的观察应加大扫描范围，显示颈部淋巴结；（3）无明显吞咽运动及血管搏动伪影，伪影不影响靶区结构的影像诊断。","style":"unordered","closed":false,"items":[]}]},"common":{"quote":false}},{"key":"header","data":{"content":"（二）颈部软组织MRI技术要点及要求","level":3},"common":{"quote":false}},{"key":"list","data":{"style":"ordered","items":[{"content":"﻿﻿线圈：颈线圈、头颈联合线圈、脊柱线圈。","style":"unordered","closed":false,"items":[]},{"content":"﻿﻿体位：仰卧位，头先进。定位中心及线圈中心对准喉结。","style":"unordered","closed":false,"items":[]},{"content":"﻿﻿方位及序列：平扫序列：以轴面为主，扫描T<sub>2</sub>WI、 fs-T<sub>2</sub>WI（STIR）、fs-T<sub>1</sub>WI序列，辅以矢状面T<sub>2</sub>WI 和T1WI 以及冠状面 fs-T2WI（STIR 或水脂分离）。扫描基线：轴面：垂直于颈部长轴，范围上至硬颚，下至胸骨切迹或覆盖病变ROI；矢状面：与颈部正中矢状线平行，范围包含颈部两侧软组织或病变ROI；冠状面：平行于颈部上下长轴，方位覆盖喉结至乳突后。增强扫描：轴面、矢状面及冠状面fs-T WI均需扫描。","style":"unordered","closed":false,"items":[]},{"content":"技术参数：层厚5.0~6.0mm，层间隔≤层厚x20%，FOV（200~260）mm×（200~260）mm，矩阵≥256×224。按照常规剂量和流率静脉注射钆对比剂。","style":"unordered","closed":false,"items":[]},{"content":"图像要求：（1）显示颈部软组织解剖结构，两侧对称显示；（2）无明显吞咽运动及血管搏动伪影。","style":"unordered","closed":false,"items":[]}]},"common":{"quote":false}},{"key":"header","data":{"content":"（三）颈部血管MRA的技术要点及要求","level":3},"common":{"quote":false}},{"key":"list","data":{"style":"ordered","items":[{"content":"﻿﻿线圈：颈线圈、头颈联合线圈、脊柱线圈。","style":"unordered","closed":false,"items":[]},{"content":"﻿﻿体位：仰卧位，头先进。定位中心及线圈中心对准两侧下颌角连线水平。","style":"unordered","closed":false,"items":[]},{"content":"﻿﻿方位及序列：（1）三维PC-MRA：冠状面扫描，包括全部颈部血管，上至基底动脉，下至主动脉号。设定相应快流速编码（50~120cm/s）约力目标血管最大流速的120%，获取颈部动脉像，设定慢流速（15~30 cm/s）获取颈部静脉及动脉像。（2）三维TOF-MRA：轴面扫描，垂直颈部血管，范围上至基底动脉，下至主动脉弓，获取颈部动脉像。（3）二维TOF-MRA：轴面扫描，垂直颈部血管，获取颈部静脉像。（4）三维对比增强MRA：冠状面扫描，包括全部颈部血管，上至基底动脉，下至主动脉弓。","style":"unordered","closed":false,"items":[]},{"content":"﻿﻿技术参数：\n（1）二维TOF-MRA：在扫描范围下游放置空间饱和带，TR、TE均为最短。\n（2）三维对比增强MRA：单期扫描时间≤20s，静脉注射钆对比剂，流率2mls，剂量0.1~0.2 mmoi/kg，然后注射等量生理盐水。扫描注射对比剂前蒙片，注射对比剂后扫描至少2个时相（动脉像及静脉像）。","style":"unordered","closed":false,"items":[]},{"content":"﻿﻿图像要求：\n（1）提供MIP 重组三维血管像；\n（2）PC法序列分别显示相应颈部动脉像或静脉像；\n（3）三维TOF-MRA 序列应显示颈部动脉像；\n（4）二维TOF-MRA序列显示颈部静脉像；\n（5）三维对比增强MRA 分别显示动脉像和静脉像，动脉像尽量减少静脉像的污染；\n（6）非对比剂法大部分血管段能显示；\n（7）血管边缘清晰锐利，无运动模糊，无明显背景软组织影，无其他伪影影响诊断。","style":"unordered","closed":false,"items":[]}]},"common":{"quote":false}}],"typeset":"typeset-1687836132043","layout":"web","basic":{"title":"","cover":"","summary":""}}